Some studies point to lower risk of certain cancers like breast cancer, but other research suggests the effect may fade over time.
Recap by typeshit. Post by @beatcancerindia on Instagram.
A Future Health & Medical Innovation panel weighs how much of the growing interest in peptides and exosomes is backed by evidence.
The aging doctor shares a headline saying new studies point to GLP-1 drugs slowing the biological clock, and notes himself that more research is needed.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
Reported oral side effects tied to GLP-1 treatment now go by an informal name, covering xerostomia, altered taste and halitosis.
Polskie Radio covers the FDA clearing Lilly's Zepbound to treat obstructive sleep apnea, an earlier approval beyond weight loss.
Loading…